• 1. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 4. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 5. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazinanes Piperazines N-alkylpiperazines

Comprehensive Overview of Piperazine, 1-(4-piperidinyl)-4-propyl-, trihydrochloride (CAS No. 873955-80-7)

Piperazine, 1-(4-piperidinyl)-4-propyl-, trihydrochloride (CAS No. 873955-80-7) is a specialized organic compound that has garnered significant attention in pharmaceutical and biochemical research. This compound, characterized by its unique piperazine and piperidinyl moieties, plays a pivotal role in the development of novel therapeutic agents. Its molecular structure, combined with the trihydrochloride salt form, enhances its solubility and stability, making it a valuable intermediate in drug synthesis.

In recent years, the demand for Piperazine derivatives has surged due to their widespread applications in medicinal chemistry. Researchers are particularly interested in this compound for its potential role in targeting central nervous system (CNS) disorders, a hot topic in modern pharmacology. With the rise of neurodegenerative diseases and mental health conditions, compounds like Piperazine, 1-(4-piperidinyl)-4-propyl-, trihydrochloride are being explored for their ability to modulate neurotransmitter systems, such as dopamine and serotonin receptors.

The synthesis and optimization of 873955-80-7 have been a focus in high-throughput screening and combinatorial chemistry. Its propyl side chain contributes to its lipophilicity, which is crucial for blood-brain barrier penetration—a key factor in CNS drug development. This property aligns with the growing trend of precision medicine, where researchers aim to design molecules with tailored pharmacokinetic profiles.

Another area of interest is the compound's potential application in cancer research. The piperazine scaffold is known for its versatility in binding to various biological targets, including kinase inhibitors and G-protein-coupled receptors (GPCRs). As the search for targeted therapies intensifies, Piperazine, 1-(4-piperidinyl)-4-propyl-, trihydrochloride could serve as a building block for next-generation antineoplastic agents.

From a technical perspective, the trihydrochloride salt form of this compound ensures better handling and storage stability, addressing common challenges in pharmaceutical manufacturing. This aspect is critical for scale-up processes and quality control, which are frequently discussed in industry forums and research publications.

In summary, Piperazine, 1-(4-piperidinyl)-4-propyl-, trihydrochloride (CAS No. 873955-80-7) represents a promising candidate in drug discovery, with applications spanning CNS therapeutics, oncology, and beyond. Its structural features and physicochemical properties make it a subject of ongoing investigation, reflecting the broader shift toward rational drug design and personalized medicine.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)